Arkolith/Insider Trading/JAZZ/Form 4

Cozadd Bruce C

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Dec 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13.8M
Net Open-Market Flow
-$13.8M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2025Sell(S)507$179.79$91K431K
Nov 26, 2025Sell(S)38K$177.27$6.8M393K
Nov 26, 2025Option exercise(M)77K$123.36$9.5M470K
Nov 26, 2025Option exercise(M)811$123.36$100K471K
Nov 26, 2025Sell(S)30K$178.06$5.4M440K
Nov 26, 2025Sell(S)8K$179.23$1.5M432K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 26, 2025Option exercise(M)811—$00
Nov 26, 2025Option exercise(M)77K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193210-25-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML